James Richardson has a diverse work experience in the healthcare industry. James is currently working at Sarepta Therapeutics as the Vice President and Head of Clinical Development since August 2023. Prior to this, they held various leadership roles at Sarepta Therapeutics, including Executive Director of Global Program Team Lead and Team Lead of Global Medical Affairs.
Before joining Sarepta Therapeutics, James worked at AstraZeneca as the Head of Medical Affairs for Cardiovascular, Metabolic, and Renal Disease from October 2017 to September 2019. James also gained experience at Boehringer Ingelheim, where they served as the Therapy Area Lead for Respiratory Medicine and held positions as a Senior Medical Advisor and Medical Advisor.
James began their career in the healthcare industry as a Cardiology Specialist Trainee at the NHS from October 2013 to March 2014. James also worked as a Cardiology Registrar (LAT) at The Heart Hospital from November 2012 to May 2013.
James Richardson completed their Bachelor of Arts (B.A.) degree in Philosophy, Psychology, and Physiology from the University of Oxford in 1999-2002. James then pursued further education at the University of Oxford, earning a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree between 2004 and 2008. In 2011, they became a Member of the Royal College of Physicians after studying at the Royal College of Physicians in London. In 2015, they obtained a Diploma in Pharmaceutical Medicine from The Faculty of Pharmaceutical Medicine.
August, 2023 - present
September, 2021
April, 2021
January, 2021
September, 2019
Senior Vice President, Head of Clinical Development at AffyImmune Therapeutics
Vice President, Head Of Clinical Development Operations at Edgewise Therapeutics
Vice President, Head Of Clinical Development Operations at Sage Therapeutics
Vice President Head Of Clinical Development at Nektar Therapeutics
Vice President, Head Of Clinical Development at Cogent Biosciences